vs
Side-by-side financial comparison of Virgin Galactic Holdings, Inc (SPCE) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Virgin Galactic Holdings, Inc is the larger business by last-quarter revenue ($4.2M vs $2.2M, roughly 1.9× Instil Bio, Inc.). Instil Bio, Inc. runs the higher net margin — -365.3% vs -2222.2%, a 1856.8% gap on every dollar of revenue. On growth, Virgin Galactic Holdings, Inc posted the faster year-over-year revenue change (125.5% vs -19.2%).
Virgin Galactic Holdings, Inc. is a British-American spaceflight company founded by Richard Branson and the Virgin Group conglomerate, which retains an 11.9% stake through Virgin Investments Limited.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
SPCE vs TIL — Head-to-Head
Income Statement — Q2 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.2M | $2.2M |
| Net Profit | $-93.8M | $-8.2M |
| Gross Margin | -546.6% | — |
| Operating Margin | -2412.1% | -426.3% |
| Net Margin | -2222.2% | -365.3% |
| Revenue YoY | 125.5% | -19.2% |
| Net Profit YoY | 30.2% | 31.1% |
| EPS (diluted) | $-4.36 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | $4.2M | $0 | ||
| Q1 24 | $2.0M | $0 |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | — | $-13.6M | ||
| Q2 25 | — | $-21.4M | ||
| Q1 25 | — | $-28.2M | ||
| Q4 24 | — | $-11.9M | ||
| Q3 24 | — | $-23.0M | ||
| Q2 24 | $-93.8M | $-14.9M | ||
| Q1 24 | $-102.0M | $-24.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -546.6% | — | ||
| Q1 24 | -1038.1% | — |
| Q4 25 | — | -426.3% | ||
| Q3 25 | — | -670.0% | ||
| Q2 25 | — | -1045.5% | ||
| Q1 25 | — | -1363.2% | ||
| Q4 24 | — | -426.1% | ||
| Q3 24 | — | -1582.8% | ||
| Q2 24 | -2412.1% | — | ||
| Q1 24 | -5599.9% | — |
| Q4 25 | — | -365.3% | ||
| Q3 25 | — | -606.0% | ||
| Q2 25 | — | -954.2% | ||
| Q1 25 | — | -1257.8% | ||
| Q4 24 | — | -428.8% | ||
| Q3 24 | — | -1541.9% | ||
| Q2 24 | -2222.2% | — | ||
| Q1 24 | -5139.1% | — |
| Q4 25 | — | $-1.13 | ||
| Q3 25 | — | $-2.01 | ||
| Q2 25 | — | $-3.24 | ||
| Q1 25 | — | $-4.32 | ||
| Q4 24 | — | $-1.82 | ||
| Q3 24 | — | $-3.54 | ||
| Q2 24 | $-4.36 | $-2.29 | ||
| Q1 24 | $-5.10 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $775.7M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $394.8M | $113.9M |
| Total Assets | $1.1B | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.6M | ||
| Q3 25 | — | $5.8M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $15.4M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | $775.7M | $6.8M | ||
| Q1 24 | $765.2M | $5.5M |
| Q4 25 | — | $113.9M | ||
| Q3 25 | — | $120.4M | ||
| Q2 25 | — | $131.7M | ||
| Q1 25 | — | $144.9M | ||
| Q4 24 | — | $169.4M | ||
| Q3 24 | — | $176.3M | ||
| Q2 24 | $394.8M | $195.0M | ||
| Q1 24 | $417.6M | $205.8M |
| Q4 25 | — | $203.5M | ||
| Q3 25 | — | $211.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $237.4M | ||
| Q4 24 | — | $263.6M | ||
| Q3 24 | — | $272.6M | ||
| Q2 24 | $1.1B | $294.3M | ||
| Q1 24 | $1.1B | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-79.1M | $-7.1M |
| Free Cash FlowOCF − Capex | $-113.5M | — |
| FCF MarginFCF / Revenue | -2690.7% | — |
| Capex IntensityCapex / Revenue | 815.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-458.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-7.1M | ||
| Q3 25 | — | $-10.6M | ||
| Q2 25 | — | $-14.8M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | $-10.6M | ||
| Q3 24 | — | $-20.1M | ||
| Q2 24 | $-79.1M | $-10.6M | ||
| Q1 24 | $-113.2M | $-14.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-113.5M | — | ||
| Q1 24 | $-126.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2690.7% | — | ||
| Q1 24 | -6362.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 815.5% | — | ||
| Q1 24 | 658.5% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
